Antitachycardia pacemakers can detect paroxysmal supraventricular tachycardias (PSVT) and interrupt them automatically by atrial overdrive pacing. In patients with PSVT, antitachycardia pacing offers a therapeutic alternative to drug treatment. The authors present the long term follow-up in their patients and explain the indication for implantation
17 patients were treated by atrial (AAI) or atrial-triggered ventricular pacing (VAT). The atrial el...
Background. Atrial fibrillation is the most frequent cardiac dysrhythmia. The aim of this study was ...
An automatic burst pacemaker (Cybertach-60) was used to treat drug-resistant recurrent ventricular t...
Antitachycardia pacemakers can detect paroxysmal supraventricular tachycardias (PSVT) and interrupt ...
This report describes the multicenter experience of the Tachylog antitachycardia pacemaker (Siemens-...
Background Antitachycardia pacing (ATP) therapies may have a role to play in treating paroxysmal atr...
There is, at present, no method to prevent sudden cardiac death. However, in patients with documente...
Pacemakers are playing an increasing role in the management of patients with tachycardia. Pacing to ...
The Intermedics Intertach 262-12 tachycardia reversion pulse generator was implanted in 14 patients ...
Electrostimulation of the heart is of three-fold value for the treatment of tachyarrhythmias: 1. It ...
AbstractNew technology has produced automatic cardioverter-defibrilla tors capable of delivering ant...
Nowadays patients suffering from supraventricular tachycardia are first treated with antiarrhythmic ...
Sustained atrial tachycardias occurring after surgery for congenital heart disease, are often diffic...
The use of an antitachycardia pacemaker for the treatment of recurrent, drug resistant nonsyncopal s...
A patient with recurrent sustained ventricular tachycardia that was resistant to both conventional a...
17 patients were treated by atrial (AAI) or atrial-triggered ventricular pacing (VAT). The atrial el...
Background. Atrial fibrillation is the most frequent cardiac dysrhythmia. The aim of this study was ...
An automatic burst pacemaker (Cybertach-60) was used to treat drug-resistant recurrent ventricular t...
Antitachycardia pacemakers can detect paroxysmal supraventricular tachycardias (PSVT) and interrupt ...
This report describes the multicenter experience of the Tachylog antitachycardia pacemaker (Siemens-...
Background Antitachycardia pacing (ATP) therapies may have a role to play in treating paroxysmal atr...
There is, at present, no method to prevent sudden cardiac death. However, in patients with documente...
Pacemakers are playing an increasing role in the management of patients with tachycardia. Pacing to ...
The Intermedics Intertach 262-12 tachycardia reversion pulse generator was implanted in 14 patients ...
Electrostimulation of the heart is of three-fold value for the treatment of tachyarrhythmias: 1. It ...
AbstractNew technology has produced automatic cardioverter-defibrilla tors capable of delivering ant...
Nowadays patients suffering from supraventricular tachycardia are first treated with antiarrhythmic ...
Sustained atrial tachycardias occurring after surgery for congenital heart disease, are often diffic...
The use of an antitachycardia pacemaker for the treatment of recurrent, drug resistant nonsyncopal s...
A patient with recurrent sustained ventricular tachycardia that was resistant to both conventional a...
17 patients were treated by atrial (AAI) or atrial-triggered ventricular pacing (VAT). The atrial el...
Background. Atrial fibrillation is the most frequent cardiac dysrhythmia. The aim of this study was ...
An automatic burst pacemaker (Cybertach-60) was used to treat drug-resistant recurrent ventricular t...
Add to ORKG